SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.

Beta cells Endocrinology G proteincoupled receptors Insulin Metabolism

Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
07 May 2024
Historique:
medline: 7 5 2024
pubmed: 7 5 2024
entrez: 7 5 2024
Statut: aheadofprint

Résumé

Pancreatic β-cell dysfunction is a key feature of type 2 diabetes, and novel regulators of insulin secretion are desirable. Here we report that the succinate receptor (SUCNR1) is expressed in β-cells and is up-regulated in hyperglycemic states in mice and humans. We found that succinate acts as a hormone-like metabolite and stimulates insulin secretion via a SUCNR1-Gq-PKC-dependent mechanism in human β-cells. Mice with β-cell-specific Sucnr1 deficiency exhibit impaired glucose tolerance and insulin secretion on a high-fat diet, indicating that SUCNR1 is essential for preserving insulin secretion in diet-induced insulin resistance. Patients with impaired glucose tolerance show an enhanced nutritional-related succinate response, which correlates with the potentiation of insulin secretion during intravenous glucose administration. These data demonstrate that the succinate/SUCNR1 axis is activated by high glucose and identify a GPCR-mediated amplifying pathway for insulin secretion relevant to the hyperinsulinemia of prediabetic states.

Identifiants

pubmed: 38713514
pii: 173214
doi: 10.1172/JCI173214
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Joan Sabadell-Basallote (J)

Unitat de Recerca, Hospital Universitari Joan XXIII, Insitut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Brenno Astiarraga (B)

Unitat de Recerca, Hospital Universitari Joan XXIII, Insitut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Carlos Castaño (C)

Unitat de Recerca, Hospital Universitari Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Miriam Ejarque (M)

Unitat de Recerca, Hospital Universitari Joan XXIII, Insitut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Maria Repollés-de-Dalmau (M)

Unitat de Recerca, Hospital Universitari Joan XXIII, Insitut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Ivan Quesada (I)

CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, ELCHE, Spain.

Jordi Blanco (J)

Departament de Medicina i Cirurgia, Universitat Rovira i Virgili, Reus, Spain.

Catalina Nuñez-Roa (C)

Unitat de Recerca, Hospital Universitari Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

M-Mar Rodríguez-Peña (MM)

Unitat de Recerca, Hospital Universitari Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Laia Martínez (L)

Unitat de Recerca, Hospital Universitari Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Dario F De Jesus (DF)

Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States of America.

Laura Marroqui (L)

CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, ELCHE, Spain.

Ramon Bosch (R)

Unitat de Recerca, Hospital Universitari Joan XXIII, Insitut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Eduard Montanya (E)

CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, ELCHE, Spain.

Francesc X Sureda (FX)

Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States of America.

Andrea Tura (A)

Institute of Neuroscience, National Research Council, Padova, Italy.

Andrea Mari (A)

Institute of Neuroscience, National Research Council, Padova, Italy.

Rohit N Kulkarni (RN)

Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States of America.

Joan Vendrell (J)

Unitat de Recerca, Hospital Universitari Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Sonia Fernández-Veledo (S)

Unitat de Recerca, Hospital Universitari Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.

Classifications MeSH